Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elie Rizkallah

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Psychiatry Research|August 13, 2024
Elevated allostatic load is associated with poorer response to repetitive transcranial magnetic stimulation in treatment-resistant depressionChristophe Longpré-Poirier, Jean-Philippe Miron, Nicolas Garel, et al.
Cannabis and Cannabinoid Research|May 21, 2024
Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled TrialFrancois-Olivier Hebert, Violaine Mongeau-Pérusse, Elie Rizkallah, et al.
Pharmacology, Biochemistry, and Behavior|April 3, 2022
Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trialElie Rizkallah, Violaine Mongeau-Pérusse, Léonardo Lamanuzzi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2021
Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trialFlorence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, et al.
Frontiers in Psychiatry|June 2, 2011
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with QuetiapineSimon Zhornitsky, Emmanuel Stip, Joelle Desfossés, et al.
BMJ Open|March 20, 2026
The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trialChristina McAnulty, Philippe Lavoie, Samuel Cyr, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Psychiatry Research|August 13, 2024
Elevated allostatic load is associated with poorer response to repetitive transcranial magnetic stimulation in treatment-resistant depressionChristophe Longpré-Poirier, Jean-Philippe Miron, Nicolas Garel, et al.
Cannabis and Cannabinoid Research|May 21, 2024
Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled TrialFrancois-Olivier Hebert, Violaine Mongeau-Pérusse, Elie Rizkallah, et al.
Pharmacology, Biochemistry, and Behavior|April 3, 2022
Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trialElie Rizkallah, Violaine Mongeau-Pérusse, Léonardo Lamanuzzi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2021
Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trialFlorence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, et al.
Frontiers in Psychiatry|June 2, 2011
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with QuetiapineSimon Zhornitsky, Emmanuel Stip, Joelle Desfossés, et al.
BMJ Open|March 20, 2026
The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trialChristina McAnulty, Philippe Lavoie, Samuel Cyr, et al.
Pageof 2